A case-control study of using carbon nanoparticles to trace decision-making lymph nodes around inferior mesenteric artery in rectal cancer.
Adenocarcinoma
/ pathology
Adult
Carbon
/ pharmacology
Case-Control Studies
Coloring Agents
/ pharmacology
Female
Humans
Laparoscopy
/ methods
Lymph Node Excision
/ methods
Lymph Nodes
/ diagnostic imaging
Male
Mesenteric Artery, Inferior
Middle Aged
Nanoparticles
/ therapeutic use
Neoplasm Staging
Outcome Assessment, Health Care
Rectal Neoplasms
/ pathology
Carbon nanoparticles
Inferior mesenteric artery
Lymph node dissection
Rectal cancer
Station 253 nodes
Journal
Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
07
04
2018
accepted:
10
08
2018
pubmed:
18
8
2018
medline:
28
3
2020
entrez:
18
8
2018
Statut:
ppublish
Résumé
Accurate identification of lymph nodes localized around inferior mesenteric artery (IMA), with or without metastasis, is of crucial importance for surgeons when dissecting D2 or D3 lymph nodes in patients with rectal cancer (RC). The following study evaluates whether carbon nanoparticles can be used for detection of decision-making lymph nodes (DLNs) in station 253 lymph nodes found around IMA during RC surgery. A total of 66 patients with rectal adenocarcinomas were recruited between January 2014 and August 2017. Patients were divided into carbon nanoparticle (CN) group and control (CL) group; for the CN group, 1 ml nanoparticles were endoscopically injected into submucosal layer of primary tumor 1 day before surgery. DLNs were defined as black-dyed nodes in CN group or macroscopic lymph nodes in CL group localized along the IMA, proximal to the origin of the left colic artery. D3 lymph nodes were dissected using laparoscopic radical resection, and then examined using pathological approach. Intra-operative and post-operative data were compared between the two groups. In CN group, black-dyed DLNs were easily found under laparoscopy; the median number of DLNs was 3 (range 1-9). In CL group, the median number of DLNs was 0 (range 0-3). Consistency between intra-operative DLNs and post-operative station 253 nodes were confirmed by pathological examination. Significant higher number of DLNs in station 253 nodes (2.91 ± 2.47 vs 0.58 ± 0.75, p < 0.001), number of station 251 nodes (12.85 ± 8.99 vs 8.09 ± 5.85, p = 0.014), number of station 253 nodes (5.21 ± 5.26 vs 3.15 ± 2.32, p = 0.045), and the number of total lymph nodes (24.06 ± 13.20 vs 16.21 ± 9.09, p = 0.007) were found in the CN group compared to CL group. Carbon nanoparticles are useful for identifying DLNs in station 253 LNs around IMA in RC. It is not necessary to perform D3 lymph node dissection if there are no intra-operative DLNs metastases in RC.
Sections du résumé
BACKGROUND
Accurate identification of lymph nodes localized around inferior mesenteric artery (IMA), with or without metastasis, is of crucial importance for surgeons when dissecting D2 or D3 lymph nodes in patients with rectal cancer (RC). The following study evaluates whether carbon nanoparticles can be used for detection of decision-making lymph nodes (DLNs) in station 253 lymph nodes found around IMA during RC surgery.
METHODS
A total of 66 patients with rectal adenocarcinomas were recruited between January 2014 and August 2017. Patients were divided into carbon nanoparticle (CN) group and control (CL) group; for the CN group, 1 ml nanoparticles were endoscopically injected into submucosal layer of primary tumor 1 day before surgery. DLNs were defined as black-dyed nodes in CN group or macroscopic lymph nodes in CL group localized along the IMA, proximal to the origin of the left colic artery. D3 lymph nodes were dissected using laparoscopic radical resection, and then examined using pathological approach. Intra-operative and post-operative data were compared between the two groups.
RESULTS
In CN group, black-dyed DLNs were easily found under laparoscopy; the median number of DLNs was 3 (range 1-9). In CL group, the median number of DLNs was 0 (range 0-3). Consistency between intra-operative DLNs and post-operative station 253 nodes were confirmed by pathological examination. Significant higher number of DLNs in station 253 nodes (2.91 ± 2.47 vs 0.58 ± 0.75, p < 0.001), number of station 251 nodes (12.85 ± 8.99 vs 8.09 ± 5.85, p = 0.014), number of station 253 nodes (5.21 ± 5.26 vs 3.15 ± 2.32, p = 0.045), and the number of total lymph nodes (24.06 ± 13.20 vs 16.21 ± 9.09, p = 0.007) were found in the CN group compared to CL group.
CONCLUSIONS
Carbon nanoparticles are useful for identifying DLNs in station 253 LNs around IMA in RC. It is not necessary to perform D3 lymph node dissection if there are no intra-operative DLNs metastases in RC.
Identifiants
pubmed: 30116952
doi: 10.1007/s00464-018-6384-9
pii: 10.1007/s00464-018-6384-9
doi:
Substances chimiques
Coloring Agents
0
Carbon
7440-44-0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
904-910Références
Surg Oncol. 2012 Sep;21(3):e111-23
pubmed: 22770982
World J Surg Oncol. 2016 Mar 24;14:88
pubmed: 27009101
Surg Endosc. 2014 Dec;28(12):3315-21
pubmed: 24935202
Surg Endosc. 2016 Apr;30(4):1294-300
pubmed: 26150223
Ann Surg Oncol. 2011 Mar;18(3):704-10
pubmed: 20857225
Eur J Surg Oncol. 2004 Apr;30(3):271-9
pubmed: 15028308
Surg Endosc. 2006 Apr;20(4):563-9
pubmed: 16391959
Ann Oncol. 2010 May;21 Suppl 5:v70-7
pubmed: 20555107
Gastric Cancer. 2014 Apr;17(2):316-23
pubmed: 23933782
Surg Endosc. 2008 Nov;22(11):2514-7
pubmed: 18288527
Surg Endosc. 2007 Jul;21(7):1131-4
pubmed: 17180275
Int J Colorectal Dis. 2008 Aug;23(8):783-8
pubmed: 18438677
PLoS One. 2015 Aug 21;10(8):e0135714
pubmed: 26296136
World J Surg. 2013 Aug;37(8):1814-20
pubmed: 23568248
Dis Colon Rectum. 2008 Jul;51(7):1139-45
pubmed: 18483828
J Clin Oncol. 2001 Jan 1;19(1):157-63
pubmed: 11134208
Br J Surg. 2006 May;93(5):609-15
pubmed: 16607682
Ann Surg. 2012 Jan;255(1):70-8
pubmed: 22133895
Jpn J Clin Oncol. 2010 Aug;40(8):746-53
pubmed: 20457722
J Am Coll Surg. 2015 Nov;221(5):923-30
pubmed: 26362137
World J Surg. 2014 Oct;38(10):2724-9
pubmed: 24803346
Pathol Res Pract. 2014 Dec;210(12):818-21
pubmed: 25282546
World J Surg Oncol. 2016 Aug 30;14(1):231
pubmed: 27577559
Int J Surg. 2016 Dec;36(Pt A):164-169
pubmed: 27989915